Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Tiziana Life Sciences PLC
TLSA | US
1.35
USD0.03
2.27%
TLSA | US
Loading StockChartView...
About Tiziana Life Sciences PLC
Sector
Healthcare
Industry
Biotechnology
Earnings date
31/12/2023
As of date
25/03/2026
Close
1.35
Open
1.32
High
1.41
Low
1.28
Tiziana Life Sciences Ltd a biotechnology company focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401) a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's graft versus host ulcerative colitis multiple sclerosis type-1 diabetes inflammatory bowel psoriasis and rheumatoid arthritis diseases. It also develops Milciclib (TZLS-201) a small molecule inhibitor of various cyclin-dependent kinases tropomycin receptor kinases and Src family kinases controlling cell growth and malignant progression of cancer; and anti- receptor (IL6R) mAb (TZLS-501) a fully human monoclonal antibody for the treatment of IL6-induced inflammation and to treat COVID-19 patients. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London the United Kingdom.Kingdom.
View LessTLSA | US
Risk
71.1
Sharpe
0.22
Luna's Score
42/100
Recommendation
Sell
Luna says (TLSA | US)
What's Working
Low Market Beta (-0.4 to 0.8)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
89.6%1 month
71.1%3 months
79.5%6 months
74.5%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
16.12
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-5.98
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-15.79M
MarketCap
137.04M
MarketCap(USD)
137.04M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-181.23
Short ratio
0.29
Short perc.
0.10
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.22
Range1M
0.37
Range3M
0.57
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.73
Price X volume
129.31K
